First Time Loading...

Ligand Pharmaceuticals Inc
NASDAQ:LGND

Watchlist Manager
Ligand Pharmaceuticals Inc Logo
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Watchlist
Price: 86.06 USD 1.22% Market Closed
Updated: May 18, 2024

Ligand Pharmaceuticals Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ligand Pharmaceuticals Inc
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Total Other Income
-$1.8m
CAGR 3-Years
5%
CAGR 5-Years
12%
CAGR 10-Years
9%
Abbvie Inc
NYSE:ABBV
Total Other Income
-$3.5B
CAGR 3-Years
12%
CAGR 5-Years
-62%
CAGR 10-Years
-78%
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$158m
CAGR 3-Years
4%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$151m
CAGR 3-Years
126%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$55.2m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
-$31.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ligand Pharmaceuticals Inc's Total Other Income?
Total Other Income
-1.8m USD

Based on the financial report for Mar 31, 2024, Ligand Pharmaceuticals Inc's Total Other Income amounts to -1.8m USD.

What is Ligand Pharmaceuticals Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
9%

Over the last year, the Total Other Income growth was 15%. The average annual Total Other Income growth rates for Ligand Pharmaceuticals Inc have been 5% over the past three years , 12% over the past five years , and 9% over the past ten years .